InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（15 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
15
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Venker Eric, 首席执行官. Director active across 2 companies, notably Immunovant, Inc.. In total, 87 filings have been logged. Breakdown: 0 buy · 15 sells. Total volume traded: €13m. History available since 25 March 2022. The latest transaction was disclosed on 20 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Venker Eric
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报87 总计
13,909 股@ US$36.84Common SharesSEC:0001140361-26-034238:0
200,000 股@ US$34.950.028% mcap10.4% 占其流量Common SharesSEC:0001140361-26-030107:1
200,000 股@ US$3.850.0031% mcap1.1% 占其流量Common SharesSEC:0001140361-26-030107:0
92,188 股@ US$14.460.017% mcap8.8% 占其流量Common StockSEC:0001764013-26-000077:0
86,629 股@ US$38.140.042% mcap21.7% 占其流量Common StockSEC:0001764013-26-000077:1
3,092 股@ US$38.480.0015% mcap0.8% 占其流量Common StockSEC:0001764013-26-000077:2
200,000 股@ US$3.850.0029% mcap3.1% 占其流量Common SharesSEC:0001635088-26-000044:0
200,000 股@ US$29.590.022% mcap24.1% 占其流量Common SharesSEC:0001635088-26-000044:1
232,252 股0Common StockSEC:0001764013-26-000034:0
368,750 股@ US$14.460.058% mcap50.0% 占其流量Common StockSEC:0001764013-26-000024:0
200,000 股@ US$3.852.8% 占其流量Common SharesSEC:0001635088-26-000026:0
7,051 股@ US$27.150.4% 占其流量Common SharesSEC:0001635088-26-000022:0
200,000 股@ US$3.851.6% 占其流量Common SharesSEC:0001635088-26-000017:0
200,000 股@ US$3.851.6% 占其流量Common SharesSEC:0001140361-26-001239:0
313,841 股@ US$3.852.6% 占其流量Common SharesSEC:0001140361-25-046786:0
200,000 股@ US$3.851.8% 占其流量Common SharesSEC:0001140361-25-045279:0
7,051 股@ US$20.270.3% 占其流量Common SharesSEC:0001140361-25-043201:0
200,000 股@ US$3.851.8% 占其流量Common SharesSEC:0001140361-25-041214:0
414,683 股@ US$15.8515.5% 占其流量Common SharesSEC:0001140361-25-038545:0
104,940 股@ US$15.854.0% 占其流量Common SharesSEC:0001140361-25-038126:0
127,355 股@ US$15.855.9% 占其流量Common SharesSEC:0001140361-25-037740:0
1,000,000 股@ US$3.8511.9% 占其流量Common SharesSEC:0001140361-25-035890:0
7,051 股@ US$11.720.3% 占其流量Common SharesSEC:0001140361-25-032404:0
198,413 股0Common SharesSEC:0001140361-25-028452:0
100,000 股@ US$3.851.4% 占其流量Common SharesSEC:0001140361-25-027005:0
87 条申报中的 25 条
About Venker Eric
Venker Eric is Directeur Général and has 84 filings in total. Among the sampled recent filings from 2022-03-29 to 2026-07-06, the sell amount is EUR 9740558, with the main transaction nature listed as Exercise of options. The companies mentioned are Roivant Sciences Ltd., where he is President & Immunovant CEO, and Immunovant, Inc., where he is Chief Executive Officer.
